Strides Pharma Inc.: Drug Recall
Recall #D-0973-2022 · 05/18/2022
Class II: Risk
Recall Details
- Recall Number
- D-0973-2022
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Strides Pharma Inc.
- Status
- Terminated
- Date Initiated
- 05/18/2022
- Location
- East Brunswick, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 381456 bottles
Reason for Recall
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Product Description
Losartan Potassium Tablets, USP, 50 mg, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No., 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram - 603 110, Tamilnadu, India, Distributed by: Strides Pharma Inc., East Brunswick, NJ 08816. 90 film coated tablets NDC 64380-934-05 1000 film coated tablets NDC 64380-934-08
Distribution Pattern
Nationwide
Other Recalls by Strides Pharma Inc.
- Class II: Risk 07/09/2025
- Class II: Risk 03/05/2025
- Class II: Risk 03/05/2025
- Class II: Risk 12/29/2023
- Class II: Risk 06/26/2023
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.